Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Aurinia Pharmaceuticals (AUPH) has a market cap of $1.06 billion USD. According to our data, Aurinia Pharmaceuticals is ranked No.4960 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.06 B |
-17.22%
|
| Dec 31, 2024 | $1.29 B |
-0.11%
|
| Dec 29, 2023 | $1.29 B |
108.10%
|
| Dec 30, 2022 | $0.62 B |
-81.11%
|
| Dec 31, 2021 | $3.27 B |
65.37%
|
| Dec 31, 2020 | $1.98 B |
-31.74%
|
| Dec 31, 2019 | $2.90 B |
197.07%
|
| Dec 31, 2018 | $0.98 B |
50.55%
|
| Dec 29, 2017 | $0.65 B |
115.71%
|
| Dec 30, 2016 | $0.30 B |
-14.98%
|
| Dec 31, 2015 | $0.35 B |
-32.14%
|
| Dec 31, 2014 | $0.52 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
| Market Cap | = | AUPH Stock Price | * | AUPH Shares Outstanding |
| = | $7.75 | * | 0.14 B | |
| = | $1.06 B |